(Q34399437)

1 August 2017

1 reference

title

Spontaneous adenocarcinoma mouse models for immunotherapy (English)

1 reference

1 August 2017

1 reference

1 reference

Gendler SJ

1

1 reference

PubMed ID

11597523

1 August 2017

Mukherjee P

series ordinal

2

1 reference

1 August 2017

1 October 2001

1 reference

Trends in Molecular Medicine

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

10

1 reference

1 August 2017

471-475

1 reference

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

The comparative pathology of human and mouse mammary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Genetic immunization against neu/erbB2 transgenic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Prostate cancer in a transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Adoptive immunotherapy prevents prostate cancer in a transgenic animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Immunotherapy of human cancer: lessons from mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Transgenic mouse models of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902124-4

7 January 2021

10.1016/S1471-4914(01)02124-4

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11597523